Romosozumab and antiresorptive treatment: the importance of treatment sequence

Cosman, F., Kendler, D. L., Langdahl, B. L., Leder, B. Z., Lewiecki, E. M., Miyauchi, A., Rojeski, M., McDermott, M., Oates, M. K., Milmont, C. E., Libanati, C., & Ferrari, S. (2022). Romosozumab and antiresorptive treatment: the importance of treatment sequence. Osteoporosis International, 33(6), 1243–1256. https://doi.org/10.1007/s00198-021-06174-0
Authors:
Felicia Cosman
David L. Kendler
Bente L. Langdahl
Benjamin Z. Leder
E. Michael Lewiecki
Akimitsu Miyauchi
Maria Rojeski
Michele McDermott
Mary K. Oates
Cassandra E. Milmont
Cesar Libanati
Serge Ferrari
Affiliated Authors:
Felicia Cosman
Author Keywords:
anabolic
antiresorptive
romosozumab
teriparatide
treatment sequence
Publication Type:
Article
Unique ID:
10.1007/s00198-021-06174-0
PMID:
Publication Date:
Data Source:
Scopus

Record Created: